Skip to content

Clinical trials

Attention Deficit Disorder with Hyperactivity trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Attention Deficit Disorder with Hyperactivity Country / region: Germany Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20043
20051
20062
20073
20087
20093
20105
20117
20128
20131
20164
20171
20182
20194
20232
20244
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50
Unknown status7
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shire10
Eli Lilly and Company8
Medice Arzneimittel Pütter GmbH & Co KG4
University of Cologne4
Boehringer Ingelheim2
Janssen-Cilag International NV2
Novartis2
Novartis Pharmaceuticals2
Prof. Huss2
University Hospital Tuebingen2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Attention Deficit Disorder with Hyperactivity61
Borderline Personality Disorder3
Oppositional Defiant Disorder3
Spasm3
Anxiety Disorders2
Mental Disorders2
Attention Deficit and Disruptive Behavior Disorders1
Color Vision Defects1
Compulsive Personality Disorder1
Depressive Disorder1

Trials

Showing 76 to 61 of 61. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.